Lv11
100 积分 2025-04-18 加入
PBPK Modeling as an Alternative Method of Interspecies Extrapolationthat Reduces the Use of Animals: A Systematic Review
9天前
已完结
Gastrointestinal Bile Salt Concentrations in Healthy Adults Under Fasted and Fed Conditions: A Systematic Review and Meta-Analysis for Mechanistic Physiologically-Based Pharmacokinetic (PBPK) Modelling
9天前
已完结
Physiologically based pharmacokinetic (PBPK) modeling of BDE-209 following oral exposure in Chinese population
9天前
已完结
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinib
1个月前
已完结
Development and validation of a sensitive LC-MS/MS assay for determination of upadacitinib in human plasma and its application in patients with inflammatory bowel disease
1个月前
已完结
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis
2个月前
已完结
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjects
2个月前
已完结
The effect of Resveratrol on the pharmacokinetic profile of tofacitinib and the underlying mechanism
2个月前
已完结
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis
2个月前
已完结
Developing a Biorelevant Dissolution Method for an Extrudable Core System (ECS) Osmotic Tablet
2个月前
已完结
皖公网安备34019202002308
